GlassScriptPhysician profile
Alexander Maximo Clavijo
NPI 1780172601
$717.85
in general payments reported to CMS, 2019-2025
13 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $142 · 2023: $178 · 2024: $286 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $164.29 | 2022-2025 | Veozah |
| Organon LLC | $104.93 | 2022-2025 | Nexplanon, Jada System |
| Hologic Sales and Service, LLC | $103.05 | 2024-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Pfizer INC. | $65.96 | 2023-2024 | |
| Abbvie INC. | $49.40 | 2022-2023 | Lo Loestrin Fe |
| Meditrina | $49.04 | 2023-2025 | |
| Exeltis, USA INC. | $44.56 | 2022-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $34.97 | 2024-2025 | |
| Coopersurgical, INC. | $32.49 | 2022-2024 | Paragard T 380a |
| Novo Nordisk INC | $23.68 | 2024 | Wegovy |
| Millicent US INC | $18.63 | 2024 | Femring, Intrarosa |
| Minerva Surgical, INC | $13.70 | 2022 | |
| Agile Therapeutics, INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Clavijo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.